Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Clinical Trials

EUROsarc logoSarcomas are rare cancers of the bone, muscle, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues. EuroSARC is a European initiative to combat rare sarcomas that includes nine clinical trials. CSM supports two of the EuroSARC trials that focus on bone cancer. 

Sharon Love and Peter Dutton

LINES: Linsitinib in advanced Ewing Sarcoma

LINES logoLINES is a multicentre international Phase II EuroSARC trial. It tests whether a dual IGF1/IR inhibitor, linsitinib, has an effect in relapsed and/or refractory Ewing sarcoma, a bone cancer. This trial is run by OCTO and is currently recruiting patients.

MEMOS: Mifamurtide (MTP-PE) In Patients With Metastatic And/Or Recurrent Osteosarcoma

MEMOS logoMEMOS is a Phase II EuroSARC trial. It tests whether a synthetic version of MDP called Mifamurtide is effective in relapsed and/or metastatic osteosarcoma patients. This trial is run by OCTO and is currently recruiting patients.